SCHEMBL4374458

SCHEMBL4374458

O=C(O)C[C@@H](c1nc2ccccc2o1)N1CCC(CCCC2=CC=C3CCCNC3N2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 14/20 0.45
ITGAV P06756 14/20 0.45
HDAC3 O15379 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC7 Q8WUI4 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC10 Q969S8 2/20 0.34
HDAC11 Q96DB2 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC9 Q9UKV0 2/20 0.34
HDAC5 Q9UQL6 2/20 0.34
ITGA2B P08514 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
ITGB5 P18084 4/20 0.31
ITGB1 P05556 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382525 0.86 ITGB3 (0.46) ITGB3ITGAVITGA2BLMNA
SCHEMBL7590648 0.85 ITGAV (0.43) ITGB3ITGAVHDAC3HDAC4HDAC1
SCHEMBL7590552 0.85 ITGAV (0.43) ITGB3ITGAVHDAC3HDAC4HDAC1
SCHEMBL7557082 0.85 ITGAV (0.43) ITGB3ITGAVHDAC3HDAC4HDAC1
SCHEMBL4363508 0.84 ITGB3 (0.65) ITGB3ITGAVITGA2BITGB5
SCHEMBL4372884 0.84 ITGB3 (0.65) ITGB3ITGAVITGA2BITGB5
SCHEMBL4370537 0.84 ITGB3 (0.65) ITGB3ITGAVITGA2BITGB5
SCHEMBL4048448 0.80 ITGB3 (0.41) ITGB3ITGAV
SCHEMBL4045463 0.80 ITGB3 (0.50) ITGB3ITGAVITGA2BITGB5
SCHEMBL4053563 0.80 ITGB3 (0.50) ITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1047425-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-04-22 EP claimed
EP-1047425-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-11-02 EP claimed
WO-1999030709-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO claimed
EP-1047425-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-04-22 EP disclosed
EP-1047425-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-11-02 EP disclosed
WO-1999030709-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed